ERBB3 and breast cancer: The identification of only two known or likely breast cancer driver mutations (GATA3 and ERBB3) in two of the specimen was not surprising, as these specimens represent pure PML lacking any invasive component, and thus should bear less genomic resemblance to breast cancer [70].